-
Allosteric PDK4 Inhibitors for Metabolic Disease
2026-08-26
The 2019 Journal of Medicinal Chemistry study identified anthraquinone-derived allosteric inhibitors of pyruvate dehydrogenase kinase 4, highlighting compound 8c as a potent biochemical inhibitor with activity in metabolic, allergic, and cancer-related models. Its combination of hit optimization, pharmacology, metabolic stability, and docking provides a useful preclinical framework for developing PDK4-directed therapies, while leaving important questions about selectivity, target engagement, and clinical translation unresolved.
-
8-Chloroadenosine for RNA Workflows
2026-08-26
8-Chloroadenosine is a high-purity nucleoside analog for testing how transcriptional suppression reshapes RNA abundance, stability, and downstream cancer-cell phenotypes. This workflow-focused guide connects product handling with the RP3-340N1.2–IL-6 mechanism reported in NSCLC and emphasizes controls that separate RNA decay from nonspecific toxicity.
-
Phosphatase Inhibitor Cocktail 2: Workflow Guide
2026-08-25
Preserve phosphorylation-dependent biology from tissue harvest through Western blotting, co-immunoprecipitation, kinase assays, and imaging workflows. This practical guide shows how a 100X aqueous cocktail can improve sample consistency while avoiding common matrix, storage, and assay-compatibility problems.
-
Bestatin (Ubenimex): From Enzyme Tool to Translation
2026-08-25
Bestatin (Ubenimex) is more than a conventional aminopeptidase inhibitor. Its selective biochemical profile, context-dependent effects in fibrin-based angiogenesis models, and relevance to multidrug resistance research make it a valuable tool for connecting enzyme inhibition with translational phenotypes.
-
Ionomycin Free Acid in FAK–TNBC Research
2026-08-24
A translational guide to using Ionomycin free acid as a controlled calcium perturbation tool for investigating FAK stability, Calpain 2-mediated proteolysis, and the FAISL axis in triple-negative breast cancer research.
-
RBMS1 Loss Enables PD-L1 Blockade in TNBC
2026-08-24
This Cell Death & Differentiation study identifies the RNA-binding protein RBMS1 as an immune-suppressive regulator in triple-negative breast cancer. RBMS1 depletion destabilizes B4GALT1 mRNA, reduces PD-L1 glycosylation and stability, and improves the activity of checkpoint blockade and CAR-T-cell approaches in experimental models.
-
TRPV1+ Nerve Stimulation Suppresses Inflammation
2026-08-23
Song et al. show that stimulating TRPV1-positive peripheral sensory nerves at the nape suppresses systemic inflammation through coordinated somatic, brainstem, autonomic, and splenic pathways. The study identifies a somato-autonomic reflex involving catecholamine release, vagal-adrenal signaling, and inflammation-related splenic gene regulation, providing a mechanistic framework for neuroimmune intervention studies.
-
L-Ornithine in Urea Cycle Research
2026-08-22
Build reproducible urea cycle, OTC, and astrocyte metabolism assays with high-purity L-Ornithine and an aqueous-first workflow. Translate liver–brain axis findings into practical dose-response, enzyme, metabolomics, and troubleshooting strategies.
-
Isradipine (Dynacirc): Neurovascular Workflows
2026-08-22
Isradipine (Dynacirc) provides a practical way to probe L-type calcium entry across neuronal and vascular models, linking neuroprotective studies with vascular smooth muscle relaxation. This guide combines compound handling, electrophysiology, assay design, and subtype-aware troubleshooting for more reproducible calcium-channel experiments.
-
Zolmitriptan Workflows for Migraine Research
2026-08-20
Build reproducible Zolmitriptan assays around receptor subtype selectivity, solvent control, and time-resolved neurovascular readouts. This practical guide also shows how lysosomal research workflows can inspire assay design without overstating evidence for antiviral or TFEB activity.
-
Redox-Responsive Peptide Coacervates for mRNA Delivery
2026-08-20
Ren and colleagues developed HBpep-SS4, a chemically defined peptide coacervate that combines mRNA encapsulation with glutathione-responsive intracellular release. The system supported diverse RNA cargos and high genome-editing activity, while offering a mechanistically distinct alternative to conventional lipid-based delivery platforms.
-
Olsalazine Sodium: Research Workflows & Uses
2026-08-19
Olsalazine Sodium supports two distinct research tracks: inflammation and colorectal cancer experiments, plus xenobiotic-clearance studies in Aedes aegypti. Its water-compatible formulation, subnanomolar macrophage chemotaxis activity, and reported tumor-model effects make it useful for mechanism-focused assays when dosing, storage, and cross-model interpretation are carefully controlled.
-
Cefodizime: From PBP Mechanism to Translation
2026-08-19
A translational perspective on Cefodizime that connects PBP-directed cell-wall disruption, immune-context experiments, resistance modeling, pharmacokinetic interpretation, and strategically designed antimicrobial research workflows.
-
Biomimetic Chromatography for Lung Permeability
2026-08-18
Dillon and colleagues evaluated mass spectrometry-compatible immobilised artificial membrane liquid chromatography and open-tubular capillary electrochromatography as biomimetic models of pulmonary drug permeability. Their results show that IAM-LC can reproduce important permeability relationships, while OT-CEC adds complementary information about phospholipid-dependent drug–membrane interactions.
-
Low-Cost Microfluidic Mixers for mRNA LNP Research
2026-08-18
Forrester and colleagues compare two low-cost microfluidic mixers with pipette mixing for lipid nanoparticle production, combining physicochemical characterization with expression studies. Their results indicate that accessible mixing approaches can support formulation screening and produce LNPs with useful size, encapsulation, and expression profiles, while also highlighting the need for orthogonal quality assessment.